相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus-Positive and -Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Seok-Jin Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Expression and clinical significance of neuropilin-1 in Epstein-Barr virus-associated lymphomas
Yong-Yao Gu et al.
CANCER BIOMARKERS (2019)
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma
Colm Keane et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor
Patrick-Pascal Strunz et al.
LEUKEMIA & LYMPHOMA (2019)
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes
Yangying Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
Thomas Mika et al.
FRONTIERS IN MEDICINE (2019)
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma
Brady E. Beltran et al.
HEMATOLOGICAL ONCOLOGY (2018)
Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
Akiko Ohashi et al.
HISTOPATHOLOGY (2017)
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Catherine Thieblemont et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Jung Yong Hong et al.
ONCOTARGET (2017)
Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study
Li-Yang Hu et al.
CHINESE JOURNAL OF CANCER (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
The biology and treatment of plasmablastic lymphoma
Jorge J. Castillo et al.
BLOOD (2015)
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
Alina Nicolae et al.
BLOOD (2015)
Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL
Fritz Offner et al.
BLOOD (2015)
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu et al.
BLOOD (2015)
Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma
Akinao Okamoto et al.
CANCER SCIENCE (2015)
Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?
Cristian Aguilar et al.
CARDIOVASCULAR PATHOLOGY (2015)
Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non-Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
Grzegorz S. Nowakowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
Zhiyu Liu et al.
MODERN PATHOLOGY (2015)
PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
Lina Quan et al.
PLOS ONE (2015)
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma - is it necessary?
Chi Young Ok et al.
ONCOTARGET (2015)
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
Ting-Xun Lu et al.
SCIENTIFIC REPORTS (2015)
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
Ai Sato et al.
CANCER SCIENCE (2014)
Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
Chi Young Ok et al.
CLINICAL CANCER RESEARCH (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
D. Rossille et al.
LEUKEMIA (2014)
Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy
Jae-Sook Ahn et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
EBV-positive diffuse large B-cell lymphoma of the elderly
Chi Young Ok et al.
BLOOD (2013)
Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression
Ling-Hua Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Benjamin J. Chen et al.
CLINICAL CANCER RESEARCH (2013)
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Vanya Icheva et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Mario Henrique M. Barros et al.
PLOS ONE (2013)
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents
Sajal K. Ghosh et al.
BLOOD (2012)
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
Santiago Montes-Moreno et al.
MODERN PATHOLOGY (2012)
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
Sajal K. Ghosh et al.
ADVANCES IN VIROLOGY (2012)
Epstein-Barr Virus-positive Diffuse Large B-cell Lymphomas of the Elderly
Patrick Adam et al.
ADVANCES IN ANATOMIC PATHOLOGY (2011)
EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru
Brady E. Beltran et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Higher Response to Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nongerminal Center B-Cell-Like Than in Germinal Center B-Cell-Like Phenotype
Francisco J. Hernandez-Ilizaliturri et al.
CANCER (2011)
EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
Brady E. Beltran et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Immune defence against EBV and EBV-associated disease
Heather M. Long et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
Jia Ruan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population
Annegret Hofscheier et al.
MODERN PATHOLOGY (2011)
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2011)
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far
Jorge J. Castillo et al.
ONCOLOGIST (2011)
Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
Bernhard Kloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Epstein-Barr virus positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
Sylvia Hoeller et al.
HUMAN PATHOLOGY (2010)
Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
Domingo Morales et al.
LEUKEMIA & LYMPHOMA (2010)
Bortezomib induce aoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells
Ping Zou et al.
JOURNAL OF VIROLOGY (2007)
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients
Takashi Oyama et al.
CLINICAL CANCER RESEARCH (2007)
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Sarah Park et al.
BLOOD (2007)
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
Susan R. Perrine et al.
BLOOD (2007)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Thomas M. Habermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease
CM Bollard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation
M Nishiu et al.
CANCER SCIENCE (2004)
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts
U Klein et al.
BLOOD (2003)
Senile EBV plus B-cell Lymphoproliferative disorders - A clinicopathologic study of 22 patients
T Oyama et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Pyothorax-associated lymphoma: A review of 106 cases
S Nakatsuka et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Pyothorax-associated lymphoma -: A peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype
B Petitjean et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma
H Yamato et al.
HISTOPATHOLOGY (2001)
分享论文
